KRAS and solitary fibrous tumor: NAB2-STAT6 gene fusion was confirmed by RNA-based next-generation sequencing (NGS), and KRAS gene mutation was identified by DNA-based NGS, which has not been previously reported in SFT and may be associated with its malignant morphology.